✦ LIBER ✦

Elevation of antibody against Epstein-Barr virus genesBRLF1andBZLF1in nasopharyngeal carcinoma

✍ Scribed by Johannes Drach; Hannes Kaufmann; Eleonora Urbauer; Susanne Schreiber; Jutta Ackermann; Heinz Huber

Publisher: Springer-Verlag
Year: 2000
Tongue: English
Weight: 117 KB
Volume: 126
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s004320050011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody against epstein-barr virus dna

Antibody against epstein-barr virus dna polymerase activity in sera of patients with nasopharyngeal carcinoma

✍ Mei-Ying Liu; Wen-Hsiang Chou; Jen-Yang Chen; Dr. Czau-Siung Yang; Louise Nutter 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB 👁 2 views

A salt-dependent DNA polymerase activity was demonstrated in the culture of an EBV-producing, lymphoblastoid cell line (NPC-204 cells) treated with 5-iodo-2'-deoxyuridine (IUdR). There was a high frequency of levels of antibody to this enzyme in sera of patients with nasopharyngeal carcinoma (NPC).

Antibody against the Epstein-Barr virus

Antibody against the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma

✍ Liu, Mei-Ying; Shih, Ya-Yi; Chou, Sheng-Ping; Chen, Chien-Jen; Sheen, Tzung-Shia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

The Epstein-Barr virus (EBV) open reading frame BHRF1, a homologue of the oncogene bcl-2, was cloned from a patient with nasopharyngeal carcinoma (NPC) and overexpressed in Escherichia coli. The resulting recombinant BHRF1 fusion protein, with an apparent molecular weight of 35 KD, was used as antig

Titers of Epstein-Barr Virus-related ant

Titers of Epstein-Barr Virus-related antibodies in nasopharyngeal carcinoma in japan

✍ Akira Tamada; Kazuo Makimoto; Hirohiko Yamabe; Joko Imai; Yorio Hinuma; Akihiro 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB

Antibody-dependent cellular cytotoxicity

Antibody-dependent cellular cytotoxicity against epstein-barr virus-associated antigens in african patients with nasopharyngeal carcinoma

✍ Gary R. Pearson; Bo Johansson; George Klein 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 562 KB

## Abstract Antibody‐dependent cellular cytotoxicity (ADCC) was performed on serum samples from African patients with nasopharyngeal carcinoma (NPC) to determine whether antibody titers determined by this assay might be of prognostic value in this disease. The serum donors were divided into two gro

Elevated serum levels of transforming gr

Elevated serum levels of transforming growth factor β1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients

✍ Jingwu Xu; José Menezes; U. Prasad; Ali Ahmad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 1 views

Nasopharyngeal carcinomas (NPCs) of non-keratinizing type are strongly associated with Epstein-Barr virus (EBV). EBV and its gene products induce the synthesis and/or release of transforming growth factor ␤1 (TGF-␤1) from human cells and platelets. TGF-␤1 is an immunosuppressive cytokine, and many t

Serum and salivary IgA antibodies agains

Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma

✍ Y. T. Foong; H. M. Cheng; C. K. Sam; J. Dillner; W. Hinderer; U. Prasad 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 376 KB 👁 1 views

## Abstract The Epstein‐Barr virus nuclear antigen I (EBNA I) is the only latent EBV antigen consistently expressed in malignant tissues of the nasopharynx. A 20‐amino‐acid synthetic peptide, p107 contains a major epitope of EBNA I. We tested sera from 210 patients with nasopharyngeal carcinoma (NP